Red blood cell distribution width to platelet ratio levels in assessment of histologic severity in patients with primary biliary cholangitis

Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C

(2016) Ergenekon Karagöz et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Red Blood Cell Distribution Width to Platelet Ratio is Related to Histologic Severity of Primary Biliary Cirrhosis

(2016) Huan Wang et al.   MEDICINE

Predictive Scores in Primary Biliary Cirrhosis

(2015) Arndt Weinmann et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Red Blood Cell Distribution Width Levels Correlate With Liver Fibrosis and Inflammation

(2015) Wen-Shen Xu et al.   MEDICINE

Noninvasive markers in the assessment and management of autoimmune liver diseases

(2014) Douglas Grunwald et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Red cell distribution width to platelet ratio: New and promising prognostic marker in acute pancreatitis

(2014) Erdinç Çetinkaya   WORLD JOURNAL OF GASTROENTEROLOGY

Red blood cell distribution width is a potential prognostic index for liver disease

(2013) Zhide Hu et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

RDW to Platelet Ratio: A Novel Noninvasive Index for Predicting Hepatic Fibrosis and Cirrhosis in Chronic Hepatitis B

(2013) Baode Chen et al.   PLoS One

Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review

(2012) Kirsten Boonstra et al.   JOURNAL OF HEPATOLOGY

Clinical Usefulness of Measuring Red Blood Cell Distribution Width in Patients with Hepatitis B

(2012) YuFeng Lou et al.   PLoS One

Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells

(2011) Virginia Knight et al.   HEPATOLOGY

Usefulness of Red Cell Distribution Width as a Prognostic Marker in Pulmonary Hypertension††Conflicts of interest: Dr. Gomberg-Maitland has received research grant support from Actelion Pharmaceuticals Ltd., Allschwil, Switzerland; CoTherix, Inc., South San Francisco, California; Encysive Pharmaceuticals Inc., Houston, Texas; Gilead Sciences Inc., Foster City, California; Eli Lilly/ICOS, Indianapolis, Indiana; Pfizer Inc., New York, New York; and United Therapeutics, Silver Spring, Maryland. Dr. Gomberg-Maitland has served as a consultant and/or on advisory boards for Encysive Pharmaceuticals Inc., Gilead Sciences Inc., Pfizer Inc., and United Therapeutics. Dr. Shah has received research grant support from Actelion Pharmaceuticals Ltd. (Entelligence Young Investigator Award) and is also the recipient of a Scientist Development Grant from the American Heart Association, Dallas, Texas.

(2009) Chetan V. Hampole et al.   AMERICAN JOURNAL OF CARDIOLOGY

Relation Between Red Cell Distribution Width and Clinical Outcomes After Acute Myocardial Infarction

(2009) Saleem Dabbah et al.   AMERICAN JOURNAL OF CARDIOLOGY

Primary biliary cirrhosis

(2009) Keith D. Lindor et al.   HEPATOLOGY

EASL Clinical Practice Guidelines: Management of cholestatic liver diseases

(2009)   JOURNAL OF HEPATOLOGY

Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis

(2009) Tamara Alempijevic et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Elevated red blood cell distribution width predicts mortality in persons with known stroke

(2008) Chizobam Ani et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES